Literature DB >> 11434778

Flexible loop of beta 2-glycoprotein I domain V specifically interacts with hydrophobic ligands.

D P Hong1, Y Hagihara, H Kato, Y Goto.   

Abstract

Beta2-glycoprotein I (beta2-GPI), which consists of four complement control protein modules and a distinctly folded fifth C-terminal domain, is an essential cofactor for the binding to phospholipids of anti-cardiolipin antibodies, isolated from patients with anti-phospholipid antibody syndrome, and its fifth domain has attracted attention as a specific phospholipid-binding site. We focused on the fifth domain of beta2-GPI (Domain V) and examined the interaction of intact Domain V, Domains IV-V, and nicked Domain V with various hydrophobic ligands, as a model molecule of phospholipid. We found that electrostatic and hydrophobic interactions are important for Domain V binding to the ligand molecules. We also found that, while Domain IV has no significant effect on the interactions with ligands, the nicked Domain V with cleavage in the flexible loop decreases the affinity, indicating that the flexible loop region is the binding site of the hydrophobic ligands. The synthetic peptide corresponding to the loop region was disordered and interacted with bis-ANS, confirming the critical role of the loop region. To clarify the nature of the interaction between the loop region and hydrophobic compounds, we prepared the reduced and alkylated Domain V, which was denatured but was assumed to be a collapsed state. Alkylation by iodoacetic acid decreased the interaction of Domain V with bis-ANS, probably because the protein net charge was decreased by the six introduced carboxyl groups and consequently the electrostatic interactions were decreased. In contrast, Domain V alkylated by iodoacetamide, therefore retaining a high positive net charge, bound bis-ANS more strongly than the intact Domain V. These results suggested that the interaction of Domain V with hydrophobic compounds through the flexible loop is similar to the binding of hydrophobic compounds to the protein folding intermediate.

Entities:  

Mesh:

Substances:

Year:  2001        PMID: 11434778     DOI: 10.1021/bi010196v

Source DB:  PubMed          Journal:  Biochemistry        ISSN: 0006-2960            Impact factor:   3.162


  6 in total

1.  The interaction of beta(2)-glycoprotein I domain V with chaperonin GroEL: the similarity with the domain V and membrane interaction.

Authors:  Masayo Gozu; Masaru Hoshino; Takashi Higurashi; Hisao Kato; Yuji Goto
Journal:  Protein Sci       Date:  2002-12       Impact factor: 6.725

2.  Membrane binding of beta2-glycoprotein I can be described by a two-state reaction model: an atomic force microscopy and surface plasmon resonance study.

Authors:  Roland Gamsjaeger; Alexander Johs; Anna Gries; Hermann J Gruber; Christoph Romanin; Ruth Prassl; Peter Hinterdorfer
Journal:  Biochem J       Date:  2005-08-01       Impact factor: 3.857

3.  Prevalence and clinical correlations of antibodies against six beta2-glycoprotein-I-related peptides in the antiphospholipid syndrome.

Authors:  Y Shoenfeld; I Krause; F Kvapil; J Sulkes; S Lev; P von Landenberg; J Font; J Zaech; R Cervera; J C Piette; M C Boffa; M A Khamashta; M L Bertolaccini; G R V Hughes; P Youinou; P L Meroni; V Pengo; J D Alves; A Tincani; G Szegedi; G Lakos; G Sturfelt; A Jönsen; T Koike; M Sanmarco; A Ruffatti; Z Ulcova-Gallova; S Praprotnik; B Rozman; M Lorber; V B Vriezman; M Blank
Journal:  J Clin Immunol       Date:  2003-09       Impact factor: 8.317

4.  Recombinant domain V of β2-glycoprotein I inhibits the formation of atherogenic oxLDL/β2-glycoprotein I complexes.

Authors:  Jingda Li; Yan Chi; Shuqian Liu; Le Wang; Renjun Wang; Xiaofei Han; Eiji Matsuura; Qingping Liu
Journal:  J Clin Immunol       Date:  2014-06-27       Impact factor: 8.317

5.  Stretched extracellular matrix proteins turn fouling and are functionally rescued by the chaperones albumin and casein.

Authors:  William C Little; Ruth Schwartlander; Michael L Smith; Delphine Gourdon; Viola Vogel
Journal:  Nano Lett       Date:  2009-12       Impact factor: 11.189

Review 6.  Antiphospholipid syndrome infectious origin.

Authors:  M Blank; R A Asherson; R Cervera; Y Shoenfeld
Journal:  J Clin Immunol       Date:  2004-01       Impact factor: 8.542

  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.